Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Treatment with sodium nitroprusside improves the endothelial function in aortic rings with endothelial dysfunction

Texto completo
Autor(es):
Buzinari, Tereza Cristina ; Oishi, Jorge Camargo ; De Moraes, Thiago Francisco ; Vatanabe, Izabela Pereira ; Selistre-de-Araujo, Heloisa Sobreiro ; Pestana, Cezar Rangel ; Rodrigues, Gerson Jhonatan
Número total de Autores: 7
Tipo de documento: Artigo Científico
Fonte: European Journal of Pharmaceutical Sciences; v. 105, p. 144-149, JUL 15 2017.
Citações Web of Science: 2
Resumo

Purpose: Verify if sodium nitroprusside (SNP) is able to improve endothelial function and if this effect is independent of nitric oxide (NO) release of the compound. Methods: Normotensive (2K) and hypertensive (2K-1C) wistar rats were used. Intact endothelium aortas were placed in a myograph and incubated with SNP: 0.1 nM; 1 nM or 10 nM during 30 min. Cumulative concentration-effect curves for acetylcholine (Ach) were realized to measure the relaxing capacity. Intracellular NO were measured (by DAF-2DA probe) in HUVEC treated with SNP 0.1 nM or DETA/NO 0.1 mu M. The detection of intracellular superoxide radical (O-2(center dot-)) was obtained by using DHE probe. Results: Treatment of 2K-1C aortic rings with SNP (0.1; 1.0 and 10 nM) improved endothelium dependent relaxation induced by acetylcholine. This improvement induced by SNP was verified at the concentration of 0.1 nM, which does not release NO, suggesting that this effect was not induced due to NO release by SNP compound. Besides, we show that the cell treatment with 0.1 nM of SNP decreased the fluorescence intensity to DHE in cells stimulated with angiotensin II. These results indicate that SNP decreases the concentration of O-2(center dot-) in HUVEC cells. Conclusions: The SNP at a concentration that does not release NO inside the cells is able to attenuate endothelial dysfunction. (AU)

Processo FAPESP: 14/02250-7 - Caracterização farmacológica dos efeitos induzidos pelo complexo de rutênio cis-[Ru(H-dcbpy-)2(Cl)(NO2-)] em células com disfunção endotelial
Beneficiário:Tereza Cristina Buzinari
Modalidade de apoio: Bolsas no Brasil - Mestrado
Processo FAPESP: 12/24477-8 - Utilização de complexos de rutênio como estratégia farmacológica para reverter e/ou prevenir a disfunção endotelial
Beneficiário:Gerson Jhonatan Rodrigues
Modalidade de apoio: Auxílio à Pesquisa - Jovens Pesquisadores